1. Zaneta Phean CIS 1055 Section 008 October 1, 2012
Pfizer
Zaneta Phean
CIS 1055 Section 008
October 1, 2012

2. About pfizer
committed to applying science and our global resources to improve health and well-being at every stage of life
provide access to safe, effective and affordable medicines and related health care services to the people who need them
leading portfolio of products and medicines that support wellness and prevention
treatment and cures for diseases across a broad range of therapeutic areas
industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer's disease and cancer
managed care organizations to world governments and non-governmental organizations
goal is to ensure that people everywhere have access to innovative treatments and quality health care
Zaneta Phean Section 008

3. timeline Zaneta Phean Section 008
1849 – 1899 In 1849, cousins Charles Pfizer and Charles Erhart founded Charles Pfizer & Company in a red brick building in Brooklyn, NY.
1900 – 1950 The new century brought prosperity to Pfizer. The pioneering of the mass production of citric acid from sugar through mold fermentation fueled growth for years.
1951 – 1999 The second half of the 1900´s saw intense pharmaceutical research and great successes for Pfizer.
2000 – Present Pfizer increases its global presence through the acquisitions of Warner-Lambert and Pharmacia. Additionally, through strategic partnerships and acquisitions of diversified businesses, such as Wyeth, Pfizer solidifies its place as one of the most diversified companies in the global health care industry. Pfizer continues to focus on applying science and the company's global resources to improve health and well-being at every stage of life.
Zaneta Phean Section 008

4. Cofounders Charles Pfizer Charles Erhart
click arrow to meet the present Executive Leadership Team
Zaneta Phean Section 008

5. Executive Leadership Team
Ian Read Chairman of the Board and Chief Executive Officer
Mikael Dolsten President, Worldwide Research & Development
Freda C. Lewis-Hall Executive Vice President, Chief Medical Officer
Geno Germano President and General Manager, Specialty Care and Oncology
Laurie Olson Executive Vice President, Strategy, Portfolio Management and Global Commercial Operations
Sally Susman Executive Vice President, Policy, External Affairs and Communications
Chuck Hill Executive Vice President, Worldwide Human Resources
Kristin Peck Executive Vice President, Worldwide Business Development and Innovation
John Young President and General Manager, Primary Care
Hugh Donnelly Vice President, Corporate Audi
Doug Lankler Executive Vice President, Chief Compliance & Risk Officer
Amy Schulman Executive Vice President and General Counsel; Business Unit Lead, Consumer Healthcare; President and General Manager, Nutrition
Olivier Brandicourt President and General Manager, Emerging Markets and Established Products
Frank D'Amelio Executive Vice President, Chief Financial Officer and Business Operations
Zaneta Phean Section 008
click arrow to go back to previous page

6. Products
Pfizer product information is intended only for residents of the United States
Pfizer medicines help to treat and prevent a range of conditions from the most common to the most challenging for people around the world
Here is a list of a few Pfizer products people may be familiar with:
Advil Brands
Centrum Brands
Chapstick
Neosporin
Robitussin
Zaneta Phean Section 008

7. Competitors Merck & Co. Inc. Novartis AG Sanofi
Drug Manufacturers - Major
Zaneta Phean Section 008

8. Recent News
September 21, 2012  — Pfizer Invites Public To View And Listen To Webcast Of October 30 Conference Call With Analysts
September 21, 2012  — ELIQUIS® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation
September 17, 2012  — Pfizer Announces Data For Investigational Compound Tofacitinib In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2012 Annual Meeting
September 17, 2012  — Pfizer To Present New Data in Lung And Kidney Cancers at The European Society For Medical Oncology 2012 Congress
September 13, 2012  — Pfizer and Waste Management Launch Online Pharmaceutical Disposal Guide
September 13, 2012  — Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Zaneta Phean Section 008

9. Zaneta Phean Section 008

10. For More Information Call Us
Customer Service and Product Inquiries:  TRY-FIRST ( )  Monday through Friday 8:00 a.m. to 8:00 p.m. EST  Corporate Office:    235 East 42nd Street  New York, NY 10017 
Frequently asked questions
Send
Zaneta Phean Section 008